Response to the Letter to the Editor: Lung Immune Prognostic Index for Outcome Prediction to Immunotherapy in Patients With NSCLC

J Thorac Oncol. 2019 Sep;14(9):e208. doi: 10.1016/j.jtho.2019.05.035. Epub 2019 Jun 7.

Authors

Michael J Sorich¹, Andrew Rowland², Christos S Karapetis³, Ashley M Hopkins²

Affiliations

¹ College of Medicine and Public Health, Flinders University, Adelaide, Australia. Electronic address: michael.sorich@flinders.edu.au.
² College of Medicine and Public Health, Flinders University, Adelaide, Australia.
³ College of Medicine and Public Health, Flinders University, Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.

PMID: 31445740
DOI: 10.1016/j.jtho.2019.05.035

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Carcinoma, Non-Small-Cell Lung*
Humans
Immunotherapy
Lung Neoplasms*
Prognosis

Substances

Antibodies, Monoclonal, Humanized
atezolizumab